These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27565898)

  • 1. Expression and purification of polioviral proteins in E. coli, and production of antisera as reagents for immunological assays.
    Uma M; Rao PP; Nagalekshmi K; Hegde NR
    Protein Expr Purif; 2016 Dec; 128():115-22. PubMed ID: 27565898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and accurate identification of poliovirus strains used for vaccine production.
    Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
    J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized Methods for Detection of Poliovirus Antibodies.
    Weldon WC; Oberste MS; Pallansch MA
    Methods Mol Biol; 2016; 1387():145-76. PubMed ID: 26983734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins.
    Liu Q; Ku Z; Cai Y; Sun B; Leng Q; Huang Z
    J Virol Methods; 2011 Apr; 173(1):115-20. PubMed ID: 21295614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against viral nonstructural proteins in response to infection with poliovirus.
    Ehrenfeld E; Brown D; Jia XY; Summers DF
    J Infect Dis; 1995 Apr; 171(4):845-50. PubMed ID: 7535829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of poliovirus neutralizing antibodies in São Paulo State, Brazil.
    Luchs A; Cilli A; Russo DH; Costa FF; Carmona Rde C; Timenetsky Mdo C
    Trans R Soc Trop Med Hyg; 2010 Sep; 104(9):625-7. PubMed ID: 20708125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human monoclonal antibodies that neutralize multiple poliovirus serotypes.
    Puligedda RD; Kouiavskaia D; Al-Saleem FH; Kattala CD; Nabi U; Yaqoob H; Bhagavathula VS; Sharma R; Chumakov K; Dessain SK
    Vaccine; 2017 Oct; 35(41):5455-5462. PubMed ID: 28343771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress with inactivated poliovirus vaccines derived from the Sabin strains.
    Doi Y; Abe S; Yamamoto H; Horie H; Ohyama H; Satoh K; Tano Y; Ota Y; Miyazawa M; Wakabayashi K; Hashizume S
    Dev Biol (Basel); 2001; 105():163-9. PubMed ID: 11763324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological and pathogenic properties of poliovirus variants selected for resistance to antiviral drug V-073.
    Kouiavskaia DV; Dragunsky EM; Liu HM; Oberste MS; Collett MS; Chumakov KM
    Antivir Ther; 2011; 16(7):999-1004. PubMed ID: 22024515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of VP0 protein of enterovirus 71 in Escherichia coli and generation of the corresponding polyclonal antibodies in guinea pigs].
    Feng YF; Liu QW; Ku ZQ; Wen JJ; Shan H; Huang Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 May; 27(5):535-8. PubMed ID: 21557912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monospecific antisera against capsid polypeptides of poliovirus type 1 distinguish antigenic structures of poliovirus proteins.
    Wiegers KJ; Dernick R
    J Gen Virol; 1983 Apr; 64 (Pt 4)():777-85. PubMed ID: 6300300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regions of poliovirus protein VP1 produced in Escherichia coli induce neutralizing antibodies.
    Hoatlin ME; Kew OM; Renz ME
    J Virol; 1987 May; 61(5):1442-7. PubMed ID: 3033273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
    Bräutigam S; Snezhkov E; Bishop DH
    Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
    Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of recombinant Potato mop-top virus coat protein in Escherichia coli and generation of antisera recognising native virus protein.
    Hélias V; Jacquot E; Guillet M; Le Hingrat Y; Giblot-Ducray D
    J Virol Methods; 2003 Jun; 110(1):91-7. PubMed ID: 12757925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
    Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
    Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic potential of parechovirus capsid proteins.
    Alho A; Marttila J; Ilonen J; Hyypiä T
    J Clin Microbiol; 2003 Jun; 41(6):2294-9. PubMed ID: 12791839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies.
    Liu Q; Huang X; Ku Z; Wang T; Liu F; Cai Y; Li D; Leng Q; Huang Z
    J Virol Methods; 2013 Jan; 187(1):127-31. PubMed ID: 23046991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis on identification and genetic character of type I vaccine-derived poliovirus in Shanxi province in 2007].
    Yan DM; Zhu SL; Zhang Y
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):131-4. PubMed ID: 20077658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.